Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and tolerability of zoledronic acid in metastatic prostate cancer patients with bone metastases treated with bisphosphon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated | Phase 4 | Status: COMPLETED